Bottlenecks in bioanalysis: where do they come from and how to remove them?-Reference-Cited by-同舟云学术

Bottlenecks in bioanalysis: where do they come from and how to remove them?

Published:2014-10 Issue: Volume: Page:94-105
ISSN:
Container-title:Eliminating Bottlenecks for Efficient Bioanalysis: Practices and Applications in Drug Discovery and Development
language:
Short-container-title:

Author:

Timmerman Philip¹

Affiliation:

1. Philip Timmerman holds a Master’s degree in biochemistry and food chemistry. He started his career as a MS scientist in the Bioanalytical Department of Janssen Pharmaceutica (Beerse, Belgium). Throughout his career, he assumed increasing scientific and managerial responsibilities and supported bioanalysis in all stages of drug R&D. From 2000 to 2010, he headed up the Bioanalytical Department of Janssen Pharmaceutica in the EU, supporting all phases of research and development. In his current position as...

Publisher

Future Science Ltd

Link

http://www.future-science.com/doi/pdf/10.4155/fseb2013.13.12

Reference23 articles.

1. US Department of Health and Human Services FDA Center for Drug Evaluation and Research Center for Veterinary Medicine . Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Center for Veterinary Medicine, MD, USA (2001) .

2. Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays

3. Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations

4. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum